शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
SOLARANSESOLARA ACTIVE PHA SCI LTD· Pharmaceuticals & BiotechnologyLowNeutral
Announced Fri, 16 Oct, 2026 · 19:22 IST

Audio recording of Q2 FY27 earnings call uploaded to website

SOLARA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-8.9%Reaction day
₹710.00
prior close
₹708.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.7%-7.2% vs market
Pharmaceuticals peers, median of 172sector-1.6%-7.3% vs sector

On the reaction day the stock moved 7.2 pts less than Nifty Microcap 250 and 7.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.6
10m
-1.4
15m
-2.7
30m
-3.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-8.9-1.7-7.2-1.6-7.3
Next day
-9.7-4.2-5.4-3.5-6.2
2d
-12.4-5.2-7.2-3.7-8.7
3d
-13.8-7.4-6.3-5.3-8.5
4d
-10.7-7.0-3.6-4.1-6.6
5d
-10.5-5.5-5.1-2.3-8.2
1w
-8.2-4.8-3.4-1.0-7.1
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Solara Active Pharma Sciences has uploaded the audio recording of its Q2 FY27 earnings call held on October 16, 2026 to its website under the Investor Relations section. The call discussed unaudited financial results for the quarter ended September 30, 2026. The filing is procedural, filed under SEBI Listing Regulations, and links to the MP3 file are provided.

Likely market impact

No direct price impact. Investors can listen to management commentary for cues on business outlook and any forward guidance.